Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian J Sweeney

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
European Neurology|August 29, 2003
Late-onset neuroaxonal leucoencephalopathy with spheroids and vascular amyloidLorna Browne, Brian J Sweeney, Michael A Farrell
Headache|January 11, 2008
A novel ATP1A2 gene mutation in an Irish familial hemiplegic migraine kindredDesiree M Fernandez, Collette K Hand, Brian J Sweeney, et al.
Journal of the Peripheral Nervous System : JPNS|August 19, 2020
Ataxia pancytopenia syndrome due to SAMD9L mutation presenting as demyelinating neuropathyDavid Vaughan, Petya Bogdanova-Mihaylova, Daniel J Costello, et al.
Epilepsy & Behavior : E&B|May 23, 2007
Clinical characteristics and outcome of patients diagnosed with psychogenic nonepileptic seizures: a 5-year reviewSean S O'Sullivan, Jennifer E Spillane, Elaine M McMahon, et al.
Cold Spring Harbor Molecular Case Studies|November 17, 2022
Germline mosaicism in a family with <i>MBD5</i> haploinsufficiencyMehak Bhatia, Gianpiero L Cavalleri, Máire White, et al.
Current Controlled Trials in Cardiovascular Medicine|July 5, 2002
A Prospective Study of Pravastatin in the Elderly at Risk (PROSPER): Screening Experience and Baseline CharacteristicsIan Ford, Gerard Jan Blauw, Michael B Murphy, et al.
Circulation|November 9, 2005
Plasma lipoproteins and apolipoproteins as predictors of cardiovascular risk and treatment benefit in the PROspective Study of Pravastatin in the Elderly at Risk (PROSPER)Chris J Packard, Ian Ford, Michele Robertson, et al.
Circulation|February 7, 2007
C-reactive protein and prediction of coronary heart disease and global vascular events in the Prospective Study of Pravastatin in the Elderly at Risk (PROSPER)Naveed Sattar, Heather M Murray, Alex McConnachie, et al.
Lancet (London, England)|November 30, 2002
Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trialJames Shepherd, Gerard J Blauw, Michael B Murphy, et al.
Journal of the American Geriatrics Society|November 6, 2007
Association between apolipoprotein E4 and cognitive decline in elderly adultsChris J Packard, Rudi G J Westendorp, David J Stott, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
European Neurology|August 29, 2003
Late-onset neuroaxonal leucoencephalopathy with spheroids and vascular amyloidLorna Browne, Brian J Sweeney, Michael A Farrell
Headache|January 11, 2008
A novel ATP1A2 gene mutation in an Irish familial hemiplegic migraine kindredDesiree M Fernandez, Collette K Hand, Brian J Sweeney, et al.
Journal of the Peripheral Nervous System : JPNS|August 19, 2020
Ataxia pancytopenia syndrome due to SAMD9L mutation presenting as demyelinating neuropathyDavid Vaughan, Petya Bogdanova-Mihaylova, Daniel J Costello, et al.
Epilepsy & Behavior : E&B|May 23, 2007
Clinical characteristics and outcome of patients diagnosed with psychogenic nonepileptic seizures: a 5-year reviewSean S O'Sullivan, Jennifer E Spillane, Elaine M McMahon, et al.
Cold Spring Harbor Molecular Case Studies|November 17, 2022
Germline mosaicism in a family with <i>MBD5</i> haploinsufficiencyMehak Bhatia, Gianpiero L Cavalleri, Máire White, et al.
Current Controlled Trials in Cardiovascular Medicine|July 5, 2002
A Prospective Study of Pravastatin in the Elderly at Risk (PROSPER): Screening Experience and Baseline CharacteristicsIan Ford, Gerard Jan Blauw, Michael B Murphy, et al.
Circulation|November 9, 2005
Plasma lipoproteins and apolipoproteins as predictors of cardiovascular risk and treatment benefit in the PROspective Study of Pravastatin in the Elderly at Risk (PROSPER)Chris J Packard, Ian Ford, Michele Robertson, et al.
Circulation|February 7, 2007
C-reactive protein and prediction of coronary heart disease and global vascular events in the Prospective Study of Pravastatin in the Elderly at Risk (PROSPER)Naveed Sattar, Heather M Murray, Alex McConnachie, et al.
Lancet (London, England)|November 30, 2002
Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trialJames Shepherd, Gerard J Blauw, Michael B Murphy, et al.
Journal of the American Geriatrics Society|November 6, 2007
Association between apolipoprotein E4 and cognitive decline in elderly adultsChris J Packard, Rudi G J Westendorp, David J Stott, et al.
Pageof 1